Latest / Public Health Review Morning Edition / 1129: The Rising Cost of Falling Vaccination Rates
Transcript
- 0:00This is Public Health Review Morning Edition for Tuesday, May
- 0:0319th, 2026. I'm John Sheehan with news from
- 0:06the. Association of State.
- 0:07And territorial health officials today, the growing health and
- 0:11economic consequences of vaccine preventable diseases.
- 0:14Ben Lopman, professor of epidemiology, global health and
- 0:18environmental health at Emory University's Rollins School of
- 0:20Public Health, discusses the new Vaccine Impact Map, an
- 0:24interactive tool designed to help public health officials
- 0:27visualize how declining vaccination coverage could
- 0:30affect their states over time. Later, Brian Patenaude,
- 0:34associate professor of economic evaluation and health economics
- 0:37at Johns Hopkins Bloomberg School of Public Health, breaks
- 0:40down the financial realities of measles outbreaks and why even
- 0:44relatively small outbreaks can carry massive costs for public
- 0:47health systems, hospitals, insurers and families.
- 0:51Let's start with Ben Lopman and Emory University's new
- 0:54interactive vaccine impact map. You know, we're obviously in a
- 0:59rather unusual policy and cultural environment right now
- 1:02with routine childhood vaccines. And, you know, we've been
- 1:07hearing all these things about how vaccination rates are
- 1:09dropping. You know, kindergarten vaccine
- 1:12coverages is going down one survey after another.
- 1:15And you know, sometimes these numbers seem quite small, one 2%
- 1:19drop. But you know, my instinct as an
- 1:21epidemiologist is that, you know, this declines in, in the
- 1:24number of kids getting vaccinated may may not be small
- 1:27at all. And as those, as those numbers,
- 1:30as those coverage comes down, you know, we're likely to see
- 1:32cases, hospitalizations, etcetera, rising.
- 1:36But we, we didn't see that there was a tool out there that was
- 1:39showing what those potential real world consequences would
- 1:42be. So my group built this, this
- 1:45tool, which we call vaccine impact Map, where you can look
- 1:49at the map and see how many children in in your state, you
- 1:52know, might become cases, become hospitalized, even deaths.
- 1:55If let's say vaccination rates go down by 5/10/20 percent, you
- 1:59know, what will be the real consequence of that.
- 2:01So we were trying to fill that gap between what we see
- 2:04happening with vaccine coverage and what that means in terms of
- 2:07real public health consequences. Yeah, and that sounds really
- 2:11helpful. I'm reminded of one of those
- 2:13flood maps where if you plug in a variable like sea level rises
- 2:172 inches, what does that mean for my neighborhood and you can
- 2:20see a visual representation of it?
- 2:22No, that's exactly, that's exactly the, the idea behind it
- 2:25is that, and these impacts will vary from state to state, right?
- 2:29Both in terms of just the number of kids in the state, what their
- 2:32birth rates are like, also where their vaccine coverage is now,
- 2:37right at states with high vaccine coverage will be
- 2:40affected potentially in different ways to those with
- 2:42relatively low vaccine coverage. And so, you know, if you can
- 2:46come to this map and say in my state what will happen if
- 2:49vaccine coverage goes down by 1510 percentage points and also
- 2:54those those impacts don't happen immediately is the the
- 2:58consequences can kind of accrue. So you can say what will be the
- 3:01impact in one year or in in five years, you know, if this trend
- 3:05continues. Wow.
- 3:07Yeah. And that that seems like it
- 3:09would make an impact. You can see taking those small
- 3:14percentage points and translating it onto, you know,
- 3:17when it's overlaid onto your community.
- 3:20Yeah, no, it it precisely. And you know, you mentioned
- 3:23percentages and the thing about percentages when you think about
- 3:27vaccine coverage rates, for example, is I think, you know,
- 3:30we they make sense to us is epidemiologist they often kind
- 3:32of hide the real, you know, the real human impact.
- 3:37You know, a 10% decline in a state with 5 million kids is
- 3:40very different than a 10% decline in a, in a small in a
- 3:44small state, for example, just in terms of sheer, sheer
- 3:46numbers. And so, you know, what this tool
- 3:49does is it kind of runs those numbers through epidemiological
- 3:52models. So this is kind of based on, you
- 3:55know, epidemiological theory and the kind of tools that we
- 3:58frequently use. And we calibrated those models
- 4:01to each state's population, like I mentioned already, birth
- 4:04rates, current vaccine coverage, etcetera.
- 4:06And so then what you get instead of just like a percentage is how
- 4:09many actual kids are are projected to be hospitalized,
- 4:16how many projected additional deaths and a dollar spent as
- 4:19well. You know, what are the economic
- 4:20consequences? And I think some of the numbers
- 4:23of this shows are quite, quite sobering.
- 4:25You know, after, for example, five year, 20% sustained drop in
- 4:30pertussis vaccination, we'd be talking it on the order of 3000
- 4:34additional hospitalizations and maybe 25 to 30 deaths every year
- 4:39across across the country. So, you know, real, real, real,
- 4:42substantial numbers. My gosh, yeah.
- 4:45And you know, hospitalizations and deaths are awful and there's
- 4:50no, there's no debating that. But I think it's useful that the
- 4:54tool also includes those economic costs.
- 4:57And it's not just sort of the the hospital bill costs.
- 5:01It's not, you know, the the direct money out of pocket
- 5:05necessarily. It's it's spread across other
- 5:09other variables. No, that's, that's exactly
- 5:11right. So I think when we think about
- 5:12the economic cost like you mentioned, we often think of the
- 5:15hospital bill of kind of a child being, you know, severe case
- 5:19being hospitalized. But that's really only kind of
- 5:22one part of the economic story. And it's especially true for for
- 5:28infections to pathogens where most cases are relatively mild.
- 5:33Most don't require hospitalization, but still, you
- 5:37know, a kid misses school, a parent has to stay home, days of
- 5:42work are missed, there's lost wages, potentially sometimes
- 5:46jobs are lost even. And so, you know, we wanted to
- 5:48include both of those so-called, you know, direct medical costs,
- 5:53but as well a lot of these kind of indirect or societal cost
- 5:57productivity losses as economists call them.
- 6:00And so you can add up, you know, these impacts both in terms of
- 6:04medical bills, but also these these societal costs.
- 6:08And the numbers can become large really, very, very quickly.
- 6:13And it's also kind of a reminder that, you know, vaccines, yes,
- 6:17they protect children directly, but they also contribute to kind
- 6:21of economic stability, productivity, because you can
- 6:24count on your nut kid not getting sick from a given a
- 6:28given vaccine preventable disease if they're vaccinated
- 6:30and. In the context of your map, you
- 6:32can see what happens and how those costs can balloon when
- 6:37vaccination rates go down even by as little as 5%.
- 6:41No, that's, that's exactly right.
- 6:43And there are these, you know, clear again, both health and
- 6:46economic consequences. I mean, vaccines are, you know,
- 6:49amongst the most extraordinary tools for public health, but
- 6:53they also have these really substantial economic, economic
- 6:57benefits. And the converse of that of
- 6:59course is true too. If we if we vaccinate fewer
- 7:02kids, those costs will kind of come back on the Ledger.
- 7:06Now in this in vaccine impact map we have, we've so far only
- 7:13included three diseases, 3 vaccine preventable diseases,
- 7:18rotavirus, main cause of diarrheal disease, pertussis,
- 7:22whooping cough and invasive bacterial disease which can be
- 7:24prevented by the pneumococcal conjugate vaccine.
- 7:28Actually just those three, those 3 vaccine preventable diseases,
- 7:33we estimate that over five years of sustained coverage decline on
- 7:38the order of, you know, as if it's as high as 20% could cost
- 7:43upwards of a billion dollars per year just for those 3 diseases.
- 7:48So, you know, in the context of the enormous savings that you
- 7:52you quoted earlier, if we choose to vaccinate less, those costs
- 7:56come back on society. And how can public health
- 8:00officials take advantage of the map?
- 8:02So I'm not sure I said where people can find the website yet.
- 8:04And that's a vax, impactmap.org and that's vax with an X and
- 8:10it's a, it's an online, freely available interactive tool that
- 8:14really anyone can use. But we really built it with kind
- 8:17of state and other public health officials and public health
- 8:20practitioners in mind. So you can go to the invoke, go
- 8:23to vaximpactmap.org right now and what you can do is you can
- 8:27select your state, you can choose a disease.
- 8:30There's a slider to decide to look at different projections of
- 8:33what what would happen if vaccine coverage goes down by
- 8:36510, fifteen, 20% and see what that decline looks like in your
- 8:40state's population. And the idea is that, you know,
- 8:44you can take the data from this, a public health practitioner and
- 8:48take this data and you'll put it in front of a governor's office
- 8:53or bring it to a legislative committee and use it in a, a
- 8:57town hall or even, you know, potentially for a discussion in
- 9:00a, in a doctor's office. You know, I, I think this is
- 9:06exactly what that this tool is for, is kind of taking the
- 9:10abstract idea of vaccine coverage and making it concrete
- 9:14in terms of disease and economic outcomes.
- 9:18And that in in doing so, putting people in a position to kind of
- 9:21act giving them the information that they that they need.
- 9:25And you mentioned that so far the map only includes a few
- 9:31diseases. It seems like the opportunity is
- 9:34there to to add to it. Are there plans to evolve it?
- 9:36Yeah, there there certainly are. You know, maybe first explain
- 9:40why we chose these these three diseases to to start with.
- 9:43And it's a it, it's a little bit of technical I suppose.
- 9:47And that, you know, these, these three vaccine preventable
- 9:52diseases again, rotavirus, diarrhea, pertussis and invasive
- 9:56bacterial disease, they are endemic infections, right?
- 10:01They're always with us, they're always being transmitted.
- 10:05And what that means is there's a pretty, there's a pretty
- 10:07predictable relationship between vaccine coverage and how many
- 10:12cases there there would be. That's very different from
- 10:15measles, for example, where there, you know, outbreaks
- 10:17occur. It's a, it's a bit random where,
- 10:19where cases might occur. And so there's measles actually
- 10:23much harder to predict. So we started with these, with
- 10:25these three for mainly for the, that, that reason is that we
- 10:30kind of we're quite confident in what the predictions would be.
- 10:33But clearly, you know, there's this phenomenon of declining
- 10:37vaccine coverage is potentially going to affect many vaccines,
- 10:41first and foremost, the ones that have been affected by this
- 10:43sort of changing policy landscape.
- 10:46Vaccines coming from universal recommendation to shared
- 10:49clinical decision making or for high risk recommendations.
- 10:52So we're looking at including vaccine preventable diseases
- 10:59like hepatitis B where there's been policy changes, potentially
- 11:03the seasonal respiratory viruses like influenza, COVID, RSV,
- 11:11respiratory syncytial virus. All of these are kind of on our
- 11:14on our on our kind of landscape of things that we will looking
- 11:18at including in the map in future, in future iterations.
- 11:21And we'll also be keeping a close eye on the policy
- 11:24environment to see where the where the kind of priority is
- 11:27there. And, and based on the map, have
- 11:30you have you seen any other interesting takeaways or or been
- 11:32able to make any forecasts regarding, regarding declining
- 11:37vaccination rates? Yeah, it's great.
- 11:38Great question. And you know, this might be a
- 11:41little bit semantic, but I I think of these as like possible
- 11:45projections rather than forecasts or predictions.
- 11:49What we wanted to do with this map is a kind of outline, you
- 11:52know, what are the possible future paths?
- 11:54What happens if in the scenario of declining vaccine coverage?
- 11:58So we are we of course not. The future is not not determined
- 12:02here. And it's our choice, you know,
- 12:04as a society, what, what happens in terms of vaccine coverage.
- 12:07But, you know, the, the point of this map is to kind of really
- 12:12show the consequences of, of, of declining vaccination.
- 12:15And so I, you know, just give a few examples of, of what some of
- 12:21the findings of, from the, from these three pathogens, if you
- 12:24want, is, you know, rotavirus, again, the cause of diarrheal
- 12:28disease. I think what's most shocking
- 12:31about rotavirus is how frequent it is.
- 12:33And so we would we predict if vaccine coverage drops by 20% of
- 12:39and is that sustained for five years, you'd be over 800
- 12:43thousand additional cases nationally per year and that's
- 12:49the majority of the cost on the order of $900 million in costs
- 12:53just from that one vaccine preventable disease pertussis.
- 12:57I think the story is really about hospitalizations up to
- 13:003000 more hospitalizations per year nationally and invasive
- 13:06pneumococcal disease which is the most tends to be the most
- 13:10severe of these. We would predict on the order of
- 13:13140 additional deaths per year with that kind of decline in
- 13:18vaccine coverage. So again, the point of this, of
- 13:20this map is, is not, is to really show what the health and
- 13:24economic impacts would be. And you know, they're not,
- 13:27they're not hypothetical. They're quite would be quite
- 13:29consequential to have these these kinds of impacts.
- 13:31Absolutely. Well, Ben Lopman, thanks so much
- 13:34for for joining. Us My pleasure.
- 13:36Thanks so much for having me. Ben Lopman, professor of
- 13:38epidemiology, global health and environmental health at Emory
- 13:42University's Rollins School of Public Health.
- 13:45Find a link to the vax impact map in the show notes.
- 13:49Now let's hear from Brian Pattanod, associate professor of
- 13:52economic evaluation and health economics at Johns Hopkins
- 13:55Bloomberg School of Public Health, on the real costs of
- 13:58measles outbreaks. So, Brian?
- 14:02I suspect I know the answer to this, but why is now the time to
- 14:06explain the cost of measles? Well, we're seeing more measles
- 14:11outbreaks than ever before in the United States.
- 14:14In the last 60 years. We have not had outbreak
- 14:17situations that have looked like we're seeing today.
- 14:20So it's particularly important to understand what are the
- 14:23implications of this for health budgets, what are the
- 14:26implications of this for households, for health systems,
- 14:30for insurance, for everyone? Yeah, what are the big findings?
- 14:34What we're seeing is that these outbreaks, even if they're very
- 14:38small can cost a lot and there's sort of a cost that's incurred
- 14:43immediately by just getting the resources moving like a getting
- 14:47contact tracers in place, getting people moving that's
- 14:49substantial. And so the more outbreaks you
- 14:52have, the more those costs accrue.
- 14:54Those don't necessarily scale evenly with the size of
- 14:57outbreaks, but they are large at the very beginning.
- 15:01And so the more you have popping up in different states,
- 15:04different areas, the greater the cost that you're incurring.
- 15:07Certainly. And there's that, as you
- 15:09mentioned, there's that upfront cost of the actual person who's
- 15:13been infected. And then there's, you know, the
- 15:16cost to health agencies to manage contacts from that
- 15:19person. Yeah, exactly.
- 15:21So we're concerned with both costs that are occurred due to
- 15:26somebody going to a hospital seeking treatment.
- 15:28All of the protocols that need to be put in place at that
- 15:30hospital to quarantine the patient and prevent the
- 15:33infection from spreading to other individuals at the
- 15:35hospital. As well as all of the costs
- 15:38associated with contact tracing, following up and making sure
- 15:41that we can connect people more fluidly to care, to prevent
- 15:45people randomly showing up at facilities and causing issues,
- 15:49and also to notify people, schools, ETC where a person has
- 15:54been. Yeah.
- 15:56And your study found that the average cost of responding to a
- 16:00measles outbreak is more than $766,000.
- 16:06How is that different from previous estimates?
- 16:09So it's it's not significantly different from previous
- 16:12estimates. We were able to leverage a bunch
- 16:15of other data that's been collected more recently because
- 16:18there have been more outbreaks. And one of the problems that we
- 16:21are really seeking to address with this study wasn't
- 16:24necessarily to try and completely differ in terms of
- 16:28averages we were getting from previous studies, but to break
- 16:31that average down to determine like what's incurred upfront,
- 16:36what's incurred on average over time and what costs actually
- 16:39scale as the outbreak gets larger.
- 16:42And previous studies weren't able to do that because most of
- 16:44the data came from pretty small outbreaks or was from like a
- 16:50partial perspective. So it wasn't fully taking into
- 16:52account all of the costs that we'd like to account for.
- 16:56There have been more studies. There have been more outbreaks
- 16:58since the kind of previous evidence was was done.
- 17:02So our average outbreak cost is roughly the same as as in the
- 17:06past that we're seeing, but those are mostly small
- 17:08outbreaks. What's particularly interesting
- 17:10is in our study we were able to separate sort of the costs that
- 17:14are occurred upfront, which are like in the ballpark of $200,000
- 17:18upfront and then the cost that scale as the outbreak grows in
- 17:22size, which is about $16,000 per additional case.
- 17:25So before, when organizations were interested in being like
- 17:30how much might an outbreak cost us, they were taking some old
- 17:32averages, which was about $43,000 per case and they were
- 17:38using that or 36 to 30 to $40,000 per case.
- 17:41And they were using that to sort of project our costs.
- 17:44What we're saying is like immediately you should probably
- 17:46consider budgeting for more than that at the upfront.
- 17:49But then as the scale goes up, it might not be as much as
- 17:52$43,000, but you do have that sort of initial upfront cost
- 17:56that's best to mobilize quickly and have available quickly.
- 17:59And so the benefit of this knowledge is really to help
- 18:02people plan better than they were able to plan before.
- 18:06And how, how can enumerating that kind of help leaders and
- 18:11officials, you know, better plan for for these outbreaks going
- 18:15forward? Well, one, it lets you have an
- 18:18idea of the resources you would need based on scenario,
- 18:21scenarios that might be predicted based on outbreak size
- 18:25and how at risk your population is.
- 18:26So we work a lot with epidemiologists.
- 18:29Obviously, they have sort of risk projections for different
- 18:32areas where they're trying to figure out, OK, what is
- 18:35vaccination coverage look like? What is sort of previous measles
- 18:38exposure look like in the population?
- 18:40How likely is it if we had somebody come in with active
- 18:42measles into that group that an outbreak would occur?
- 18:46What do we think based on some scenarios that size might be?
- 18:49And then you can use our data to predict, like in order to be
- 18:53able to respond to that outbreak, how much money would
- 18:55you need to be able to tap into and how much do you think that
- 18:57would cost? So that's how we kind of work
- 19:00from a planning aspect with epidemiologists to use this
- 19:05data. But another thing that's
- 19:06important is just understanding what does the burden of this is
- 19:10and who bears that burden? And what would those individuals
- 19:14or organizations be otherwise doing with this money if they
- 19:18didn't need to do it? And just to have an idea at
- 19:20scale of what the implications are of things that affect
- 19:25measles outbreak potential, because those are causing
- 19:28resources to be diverted away from things that they otherwise
- 19:32would be funding. We don't have a ton of excess
- 19:35floating around in our healthcare budgets.
- 19:37Healthcare is expensive. So we call this opportunity cost
- 19:40in economics. But the opportunity cost is
- 19:42particularly important to understand.
- 19:44So part of what we're doing is to help people be prepared and
- 19:47know what to budget, but part of it is just so that policy makers
- 19:50and decision makers understand what the opportunity cost of the
- 19:53situation we're in is. Yeah, absolutely.
- 19:56I mean, make the case to the legislators and, and, and policy
- 19:59makers that by the way, the cost of not making certain
- 20:04legislation or not doing, not enforcing certain regulations is
- 20:08going to be, you know, X number of dollars in potential outbreak
- 20:12scaled. However many times.
- 20:14Yep, exactly. And to help people think about
- 20:17this, we've we've actually produced what will be released
- 20:20shortly as an Open Access web-based application that you
- 20:24can work with, with models and you can work with our data and
- 20:28kind of project out costs for and who would bear the burden.
- 20:31So we break it down by, is this something that hospital systems
- 20:35pay and are reimbursed for? Does it come from federal
- 20:37dollars or state dollars? Likely in your setting, how much
- 20:42is expected to be a sort of public health department
- 20:45expense? And how much is like for
- 20:48treatment cost or something going to be reimbursed by
- 20:50Medicaid or by one of those organizations directly to the
- 20:55patient or to the hospital system who's providing care?
- 20:57So we try to break those out to be informative about where these
- 21:00resources might be coming from. And so not the full cost of all
- 21:04of this is going to be borne by 1 entity, as I've mentioned
- 21:06before. And this sort of helps people
- 21:08who are involved with planning tease that out a little bit.
- 21:12Well, Brian Patton, odd. Thanks so much.
- 21:14Yeah, thank you for having me. Happy to chat.
- 21:16Brian Patton, ODD is an associate professor of economic
- 21:19evaluation and health economics at Johns Hopkins Bloomberg
- 21:22School of Public Health. Earlier, we heard from Ben
- 21:25Lopman, professor of epidemiology, global health and
- 21:28environmental health at Emory University's Rollins School of
- 21:31Public Health. Join ASTO for a webinar May 20th
- 21:35to explore how to build resilient dialysis systems and
- 21:38teams. Understanding the structures,
- 21:41processes, and practices that influence patient safety during
- 21:44times of stress is essential to informing priorities and
- 21:47targeting interventions that strengthen resilience.
- 21:51This one hour session convenes frontline clinicians, workforce
- 21:54leaders, and public health partners to examine practical
- 21:57evidence informed strategies that enhance both system and
- 22:00worker resilience in the outpatient dialysis setting.
- 22:03The link to register is in the show notes.
- 22:07ASTO is accepting applications for the implementing pharmacist
- 22:10prescribed Contraception learning community.
- 22:13This opportunity will support state and territorial health
- 22:15agencies with technical assistance to develop
- 22:17sustainable pharmacist prescribed contraception
- 22:20programs, including workforce capacity, reimbursement pathways
- 22:24and patient awareness efforts to improve access to contraception.
- 22:28The deadline to apply is May 31st, 2026 by 5:00 PM Eastern.
- 22:33Find more information at the link in the show notes.
- 22:37This has been public health review morning edition.
- 22:39I'm John Sheehan for the Association of State and
- 22:41Territorial Health Officials.